Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,292
  • Shares Outstanding, K 23,401
  • Annual Sales, $ 6,210 K
  • Annual Income, $ -19,920 K
  • 60-Month Beta 0.83
  • Price/Sales 7.45
  • Price/Cash Flow N/A
  • Price/Book 1.04
Trade NSPR with:

Options Overview Details

View History
  • Implied Volatility 128.14% ( -10.64%)
  • Historical Volatility 56.71%
  • IV Percentile 56%
  • IV Rank 39.59%
  • IV High 306.64% on 06/08/23
  • IV Low 11.18% on 02/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 530
  • Open Int (30-Day) 456

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 1
  • High Estimate -0.15
  • Low Estimate -0.15
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +71.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +5.52%
on 04/25/24
2.4500 -22.04%
on 03/28/24
-0.4000 (-17.32%)
since 03/25/24
3-Month
1.8100 +5.52%
on 04/25/24
3.0741 -37.87%
on 01/30/24
-1.0300 (-35.03%)
since 01/25/24
52-Week
1.0300 +85.44%
on 04/28/23
3.8500 -50.39%
on 10/12/23
+0.8500 (+80.19%)
since 04/25/23

Most Recent Stories

More News
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development

NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc . (Nasdaq: NSPR), developer of the CGuardâ„¢ Embolic Prevention...

NSPR : 1.9100 (+3.24%)
InspireMD Reports Second Quarter 2022 Financial Results and Provides Business Update

- Generated 47.8% growth in CGuardâ„¢ revenue year-over-year - - Delivered several presentations at LINC 2022 featuring CGuardâ„¢ EPS, including a...

NSPR : 1.9100 (+3.24%)
InspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update

- Conference call and webcast to be held at 8:30 a.m. EDT - TEL AVIV, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR),...

NSPR : 1.9100 (+3.24%)
InspireMD Announces Appointment of Endovascular Pioneer Dr. Juan Parodi as Strategic Advisor

Credited with performing the first ever endovascular repair procedure in 1990...

NSPR : 1.9100 (+3.24%)
InspireMD Provides Highlights from Recent Presentations and Live Case Transmission at LINC 2022

Successful live case transmission again demonstrated CGuard’s™ differentiated patient protection features and ease of use...

NSPR : 1.9100 (+3.24%)
InspireMD’s CGuard™ Embolic Prevention Stent System to be Featured in Clinical Presentations and a Live Case Transmission at LINC 2022

Live case transmission designed to demonstrate ease-of-use and exceptional patient safety features of CGuardâ„¢ Embolic Prevention System (EPS) ...

NSPR : 1.9100 (+3.24%)
InspireMD Reports First Quarter 2022 Financial Results and Business Update

           - 20% growth in CGuard™ revenue Year-over-Year -            - C-Guardian FDA IDE Trial Completes First European Enrollment -            - Held...

NSPR : 1.9100 (+3.24%)
InspireMD to Report First Quarter 2022 Financial Results on May 10, 2022 and Provide Corporate Business Update

Earnings Conference Call to be held Tuesday, May 10, 2022, at 8:30 a.m. ET...

NSPR : 1.9100 (+3.24%)
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Prevention in combination with the CGuardâ„¢ Stent Platform & MicroNetâ„¢ Portfolio

Tuesday, March 22nd @ 2 p.m. ET...

NSPR : 1.9100 (+3.24%)
InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results

- CGuard™ Revenue Generated 87.5% growth over Q4’20 and 55.9% Year-over-Year –- - Published CGuard Clinical trial results in Journals of the...

NSPR : 1.9100 (+3.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

3rd Resistance Point 2.0290
2nd Resistance Point 1.9932
1st Resistance Point 1.9216
Last Price 1.9100
1st Support Level 1.8142
2nd Support Level 1.7784
3rd Support Level 1.7068

See More

52-Week High 3.8500
Fibonacci 61.8% 2.7728
Fibonacci 50% 2.4400
Fibonacci 38.2% 2.1072
Last Price 1.9100
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar